New findings highlight bias in research on health benefits of non-alcoholic drinks
Researchers from the Children 's Hospital, Boston, USA and the Center for Science in the Public Interest, Washington, D. C., USA, have found that there is a high potential for research findings into non-alcoholic drinks to be affected by bias from companies providing funding.
Previous studies on the relationship between funding source of pharmaceutical trials have shown that the outcome of published research often favors the funding organizations. However, it has not previously been clear how much this bias extends beyond drug research.
The researchers, led by David S. Ludwig, examined 206 review and research articles, published between January 1999 and December 2003, which discussed soft drinks, fruit juices, and milk, and categorized them in relation to their health outcomes, as well as by who funded the study. The relation between the funding and the outcomes was then examined.
There was a strong association between the source of the funding for these studies and the conclusions that were drawn. Research funded completely by food and drink companies was approximately four to eight times more likely to produce results which were favorable to these companies, compared with studies with no industry funding.
This research was confined to just soft drinks, juice, and milk, and hence without further studies it is important not to extrapolate the results to other types of food. However, the authors conclude that "Industry funding of nutrition-related scientific articles may bias conclusions in favor of sponsors' products, with potentially significant implications for public health."
Citation: Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS (2007) Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 4(1): e5.
PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040005
PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-01-ludwig.pdf
CONTACT:
Andrea Duggan
Department of Public Affairs
Children's Hospital Boston,
Boston, MA United States of America
+1 617-355-6420
andrea.duggan@childrens.harvard.edu
Related PLoS Medicine Perspectives articles:
Citation: Katan MB (2007) Does industry sponsorship undermine the integrity of nutrition research? PLoS Med 4(1): e6.
PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perl serv/?request=get-document&doi=10.1371/journal.pmed.0040006
PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-01-katan.pdf
CONTACT:
Martijn Katan
Vrije Universiteit Amsterdam
Amsterdam, Netherlands
+31 20 59 82610
katan99@falw.vu.nl
New treatment for schistosomiasis (bilharzia)
A significant reduction in parasite burden and pathology by a vinyl sulfone cysteine protease inhibitor suggests a new direction for chemotherapy of human schistosomiasis.
Citation: Abdulla M, Lim KC, Sajid M, McKerrow JH, Caffrey CR (2007) Schistosomiasis mansoni: Novel chemotherapy using a cysteine protease inhibitor. PLoS Med 4(1): e14.
PL EASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040014
PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-01-caffrey.pdf
CONTACTS:
Conor Caffrey
Sandler Center for Basic Research in Parasitic Diseases
Department of Pathology
QB3-Byers Hall, 1700 4th Street
San Francisco, CA 94158-2330 United States of America
+1 415 502 6866
caffrey@cgl.ucsf.edu
* * * * * * * * EMBARGO: MONDAY, 8 January, 5 P.M. PST * * * * * * *
PLEASE MENTION THE OPEN-ACCESS JOURNAL PLoS MEDICINE (www.plosmedicine.org) AS THE SOURCE FOR THESE ARTICLES AND PROVIDE A LINK TO THE FREELY-AVAILABLE TEXT. THANK YOU.
All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere--to read, download, redistribute, include in databases, and otherwise use--subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.
About PLoS Medicine
PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org
Journal
PLoS Medicine